Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1, Single Center Study Using Omalizumab in Subjects With Atopic Dermatitis

NCT01678092 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01678092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01678092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1, Single Center Study Using Omalizumab in Subjects With Atopic Dermatitis
Lead sponsor
Stanford University
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2004
Completion date
December 31, 2006
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis